Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Public ClinicalTrials.gov record NCT02651714. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Study identification
- NCT ID
- NCT02651714
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Vanda Pharmaceuticals
- Industry
- Enrollment
- 168 participants
Conditions and interventions
Conditions
Interventions
- Tradipitant Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 18, 2016
- Primary completion
- Aug 3, 2017
- Completion
- Aug 3, 2017
- Last update posted
- Jun 12, 2024
2016 – 2017
United States locations
- U.S. sites
- 28
- U.S. states
- 16
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanda Investigational Site | Encinitas | California | 92024 | — |
| Vanda Investigational Site | Encino | California | 91436 | — |
| Vanda Investigational Site | Lomita | California | 90717 | — |
| Vanda Investigational Site | San Diego | California | 92122 | — |
| Vanda Investigational Site | San Diego | California | 92123 | — |
| Vanda Investigational Site | Miami | Florida | 33126 | — |
| Vanda Investigational Site | Miami | Florida | 33136 | — |
| Vanda Investigational Site | Ormond Beach | Florida | 32174 | — |
| Vanda Investigational Site | Columbus | Georgia | 31904 | — |
| Vanda Investigational Site | Plainfield | Indiana | 46168 | — |
| Vanda Investigational Site | Crowley | Louisiana | 70526 | — |
| Vanda Investigational Site | St Louis | Missouri | 63110 | — |
| Vanda Investigational Site | Las Vegas | Nevada | 89119 | — |
| Vanda Investigational Site | New York | New York | 10022 | — |
| Vanda Investigational Site | New York | New York | 10075 | — |
| Vanda Investigational Site | High Point | North Carolina | 27262 | — |
| Vanda Investigational Site | Wilmington | North Carolina | 28405 | — |
| Vanda Investigational Site | Winston-Salem | North Carolina | 27104 | — |
| Vanda Investigational Site | Portland | Oregon | 97239 | — |
| Vanda Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Vanda Investigational Site | Johnston | Rhode Island | 02919 | — |
| Vanda Investigational Site | Charleston | South Carolina | 29407 | — |
| Vanda Investigational Site | Houston | Texas | 77030 | — |
| Vanda Investigational Site | Pflugerville | Texas | 78660 | — |
| Vanda Investigational Site | San Antonio | Texas | 78218 | — |
| Vanda Investigational Site | West Jordan | Utah | 84088 | — |
| Vanda Investigational Site | Seattle | Washington | 98101 | — |
| Vanda Investigational Site | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02651714, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02651714 live on ClinicalTrials.gov.